Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DBJ50D
|
|||
| Drug Name |
TAK-062
|
|||
| Synonyms |
zamaglutenase
Click to Show/Hide
|
|||
| Drug Type |
Enzyme replacement
|
|||
| Indication | Coeliac disease [ICD-11: DA95; ICD-10: K90.0; ICD-9: 579] | Phase 2 | [1] | |
| Company |
Takeda
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05353985) A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of TAK-062 for the Treatment of Active Celiac Disease in Subjects Attempting a Gluten-Free Diet. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.